Álvarez, Pilar
Bellosillo, Beatriz
Colom, Francesc
Longarón, Raquel
Barrera-Conde, Marta
Fernández-Ibarrondo, Lierni
Toll, Alba
Ginés, José María
de la Torre, Rafael
Pérez-Solá, Víctor
Robledo, Patricia
Funding for this research was provided by:
Instituto de Salud Carlos III (PI15/0039)
Generalitat de Catalunya
Centro de Investigación Biomédica en Red de Salud Mental
Article History
Received: 1 March 2023
Accepted: 1 July 2023
First Online: 13 July 2023
Declarations
:
: Beatriz Bellosillo received honoraria for speaker, consultancy or advisory role from Amgen, Astra-Zeneca, Biocartis, Janssen, Lilly, Merck-Serono, Novartis, Qiagen, Roche Diagnostics, Roche Pharma, ThermoFisher, Pfizer and BMS. The other declare no competing interests.